Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

T J A van Nijnatten

Showing results (1-10 of 32) with videos related to

Pageof 4
Sort By:
European Journal of Radiology|May 5, 2022
Axillary lymph node characteristics in breast cancer patients versus post-COVID-19 vaccination: Overview of current evidence per imaging modalityT J A van Nijnatten, M S Jochelson, M B I Lobbes
European Journal of Radiology|August 6, 2021
Contrast enhanced mammography (CEM) versus magnetic resonance imaging (MRI) for staging of breast cancer: The pro CEM perspectiveM B I Lobbes, E M Heuts, M Moossdorff, et al.
European Journal of Radiology|November 21, 2023
Corrigendum to "Overview of trials on artificial intelligence algorithms in breast cancer screening - A roadmap for international evaluation and implementation" [Eur. J. Radiol. 167 (2023) 111087]T J A van Nijnatten, N R Payne, S E Hickman, et al.
European Journal of Radiology|September 10, 2023
Overview of trials on artificial intelligence algorithms in breast cancer screening - A roadmap for international evaluation and implementationT J A van Nijnatten, N R Payne, S E Hickman, et al.
European Journal of Radiology|November 18, 2019
Exploring breast cancer response prediction to neoadjuvant systemic therapy using MRI-based radiomics: A systematic reviewR W Y Granzier, T J A van Nijnatten, H C Woodruff, et al.
European Journal of Radiology|October 18, 2024
Understanding the risk of ionizing radiation in breast imaging: Concepts and quantities, clinical importance, and future directionsS Di Maria, T J A van Nijnatten, C R L P N Jeukens, et al.
European Journal of Radiology|January 18, 2024
Contrast-enhanced breast imaging: Current status and future challengesT J A van Nijnatten, S Morscheid, P A T Baltzer, et al.
Breast Cancer Research and Treatment|December 5, 2016
Does the TNM classification of solitary internal mammary lymph node metastases in breast cancer still apply?V Habraken, T J A van Nijnatten, L de Munck, et al.
European Journal of Radiology|October 6, 2024
Differences in axillary ultrasound protocols among prospective de-escalating axillary surgical staging trials in clinically node negative early breast cancer patientsT J A van Nijnatten, S P Poplack, R A Wijgers, et al.
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|September 3, 2015
The diagnostic performance of sentinel lymph node biopsy in pathologically confirmed node positive breast cancer patients after neoadjuvant systemic therapy: A systematic review and meta-analysisT J A van Nijnatten, R J Schipper, M B I Lobbes, et al.
Pageof 4

Showing results (1-10 of 32) with videos related to

Sort By:
Pageof 4
European Journal of Radiology|May 5, 2022
Axillary lymph node characteristics in breast cancer patients versus post-COVID-19 vaccination: Overview of current evidence per imaging modalityT J A van Nijnatten, M S Jochelson, M B I Lobbes
European Journal of Radiology|August 6, 2021
Contrast enhanced mammography (CEM) versus magnetic resonance imaging (MRI) for staging of breast cancer: The pro CEM perspectiveM B I Lobbes, E M Heuts, M Moossdorff, et al.
European Journal of Radiology|November 21, 2023
Corrigendum to "Overview of trials on artificial intelligence algorithms in breast cancer screening - A roadmap for international evaluation and implementation" [Eur. J. Radiol. 167 (2023) 111087]T J A van Nijnatten, N R Payne, S E Hickman, et al.
European Journal of Radiology|September 10, 2023
Overview of trials on artificial intelligence algorithms in breast cancer screening - A roadmap for international evaluation and implementationT J A van Nijnatten, N R Payne, S E Hickman, et al.
European Journal of Radiology|November 18, 2019
Exploring breast cancer response prediction to neoadjuvant systemic therapy using MRI-based radiomics: A systematic reviewR W Y Granzier, T J A van Nijnatten, H C Woodruff, et al.
European Journal of Radiology|October 18, 2024
Understanding the risk of ionizing radiation in breast imaging: Concepts and quantities, clinical importance, and future directionsS Di Maria, T J A van Nijnatten, C R L P N Jeukens, et al.
European Journal of Radiology|January 18, 2024
Contrast-enhanced breast imaging: Current status and future challengesT J A van Nijnatten, S Morscheid, P A T Baltzer, et al.
Breast Cancer Research and Treatment|December 5, 2016
Does the TNM classification of solitary internal mammary lymph node metastases in breast cancer still apply?V Habraken, T J A van Nijnatten, L de Munck, et al.
European Journal of Radiology|October 6, 2024
Differences in axillary ultrasound protocols among prospective de-escalating axillary surgical staging trials in clinically node negative early breast cancer patientsT J A van Nijnatten, S P Poplack, R A Wijgers, et al.
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|September 3, 2015
The diagnostic performance of sentinel lymph node biopsy in pathologically confirmed node positive breast cancer patients after neoadjuvant systemic therapy: A systematic review and meta-analysisT J A van Nijnatten, R J Schipper, M B I Lobbes, et al.
Pageof 4